Halozyme Therapeutic (HALO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 60,108 | 402,710 | 335,940 | 119,353 | 27,895 |
| Depreciation Amortization | 2,290 | 8,896 | 6,416 | 4,124 | 1,830 |
| Income taxes - deferred | 12,926 | -155,434 | -142,481 | N/A | N/A |
| Accounts receivable | -22,787 | 6,755 | -14,369 | -55,466 | 9,339 |
| Other Working Capital | -32,166 | 2,242 | -19,033 | -59,162 | 2,891 |
| Other Operating Activity | 27,426 | 34,271 | 50,451 | 86,336 | 16,341 |
| Operating Cash Flow | $47,797 | $299,440 | $216,924 | $95,185 | $58,296 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -48,815 | -404,832 | -105,521 | -89,063 | -44,980 |
| PPE Investments | -490 | -1,457 | -1,299 | -803 | -270 |
| Investing Cash Flow | $-49,305 | $-406,289 | $-106,820 | $-89,866 | $-45,250 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 784,875 | 784,875 | 784,875 | 784,875 |
| Debt Repayment | N/A | -369,064 | -369,064 | -369,064 | -369,064 |
| Common Stock Issued | 624 | 12,536 | 8,226 | 3,578 | -602 |
| Common Stock Repurchased | N/A | -350,058 | -189,737 | -125,021 | -76,179 |
| Other Financing Activity | 0 | -424 | -424 | -424 | -329 |
| Financing Cash Flow | $624 | $77,865 | $233,876 | $293,944 | $338,701 |
| Beginning Cash Position | 119,219 | 148,203 | 148,203 | 148,203 | 148,203 |
| End Cash Position | 118,335 | 119,219 | 492,183 | 447,466 | 499,950 |
| Net Cash Flow | $-884 | $-28,984 | $343,980 | $299,263 | $351,747 |
| Free Cash Flow | |||||
| Operating Cash Flow | 47,797 | 299,440 | 216,924 | 95,185 | 58,296 |
| Capital Expenditure | -490 | -1,457 | -1,299 | -803 | -270 |
| Free Cash Flow | 47,307 | 297,983 | 215,625 | 94,382 | 58,026 |